Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Ductal Carcinoma in Situ
Interventions: DRUG: lapatinib
Sponsor: Indiana University
Collaborators: GlaxoSmithKline